Rasagiline
Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases. (In Vitro) :Rasagiline (0.25 nM; 96 hours) significantly increases the proliferation rates of SH-SY5Y and 1242-MG upon Dexamethasone (10 μM) treatment. (In Vivo) :Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Motor behavioural tests show improvements in motor deficits associated with 2.5 mg/kg Rasagiline therapy.
Product Specifications
CAS Number
136236-51-6
Product Name Alternative
Azilect
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Soluble in Water
Smiles
C#CCN[C@@H]1CCc2c1cccc2
Molecular Formula
C12H13N
Molecular Weight
171.24
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1-Indanamine, N-2-propynyl-, (R) -
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Clostridium Perfringens murB Protein (aa 1-304)
Nck (NCK1, NCK adaptor protein 1, Cytoplasmic protein NCK1, MGC12668, Nck-1, NCKalpha, SH2/SH3 adaptor protein NCK-alpha) (HRP)
Nck (NCK1, NCK adaptor protein 1, Cytoplasmic protein NCK1, MGC12668, Nck-1, NCKalpha, SH2/SH3 adaptor protein NCK-alpha) (HRP)